Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

17.32
-0.9200-5.04%
Post-market: 17.390.0700+0.40%17:51 EDT
Volume:4.14M
Turnover:72.75M
Market Cap:1.70B
PE:-6.69
High:18.27
Open:18.03
Low:17.31
Close:18.24
Loading ...

Sarepta Therapeutics Says Duchenne Muscular Dystrophy Treatment Gets Approval in Japan

MT Newswires Live
·
13 May

Sarepta announces Japan approval for Elevidys

TIPRANKS
·
13 May

Sarepta Therapeutics Secures Regulatory Approval in Japan for ELEVIDYS Gene Therapy to Treat Duchenne Muscular Dystrophy

Reuters
·
13 May

Sarepta Therapeutics Inc: Eligible to Receive up to $103.5M in Near-Term Regulatory & Commercial Milestone Payments

THOMSON REUTERS
·
13 May

Sarepta Therapeutics Announces Approval in Japan of Elevidys, a Gene Therapy to Treat Duchenne Muscular Dystrophy

THOMSON REUTERS
·
13 May

Arrowhead Pharmaceuticals Reports $542.7M Q2 Revenue, Swings to $370.4M Net Income; EPS Rises to $2.75

Reuters
·
13 May

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and TransMedics Group (TMDX)

TIPRANKS
·
09 May

Sarepta Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
08 May

UBS Cuts Price Target on Sarepta Therapeutics to $85 From $188, Keeps Buy Rating

MT Newswires Live
·
08 May

Sarepta downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
08 May

Sarepta Therapeutics’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
08 May

Post-Bell | U.S. Stocks Close Higher; Disney Surges 11%; Nvidia Jumps 3%; Alphabet Sinks 7%; Upstart Plunges 10%

Tiger Newspress
·
08 May

Sarepta Therapeutics Stock Sinks On Gloomy Forecast, Analysts Expect Demand To Pick Up

Benzinga
·
08 May

Sarepta price target lowered to $125 from $183 at Needham

TIPRANKS
·
07 May

Sarepta Therapeutics Stock Plunges on Guidance Cut. Its 'Moneymaker' Is Under Fire. -- Barrons.com

Dow Jones
·
07 May

Sarepta Therapeutics Inc : RBC Cuts Target Price to $58 From $87

THOMSON REUTERS
·
07 May

Sarepta Therapeutics Shares Fall 15.5% After Co Lowers FY Product Revenue Forecast

THOMSON REUTERS
·
07 May

Sarepta Therapeutics Analysts Slash Their Forecasts After Q1 Results

Benzinga
·
07 May

BUZZ-U.S. STOCKS ON THE MOVE-Rockwell Automation, AvidXchange, BorgWarner

Reuters
·
07 May

Sarepta Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
07 May